Atlas Trials

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

Clinical trial NCT06870435 · RECRUITING

Trial details

NCT number
NCT06870435
Sponsor
Ming-Yuan Chen
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma (NPC)ScreeningEpstein Barr Virus
Start date
2025-01-24
Primary completion
2026-01-23
Enrollment
68649

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.